Neuburgh Advisers’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$64.1M Buy
495,792
+41,440
+9% +$5.46M 1.99% 9
2019
Q2
$63.3M Buy
454,352
+26,816
+6% +$3.71M 2.04% 9
2019
Q1
$59.8M Buy
427,536
+11,680
+3% +$1.56M 2.03% 8
2018
Q4
$53.7M Sell
415,856
-784
-0.2% -$109K 2.11% 7
2018
Q3
$57.6M Sell
416,640
-31,216
-7% -$4.15M 1.86% 10
2018
Q2
$54.3M Sell
447,856
-30,400
-6% -$3.79M 1.81% 10
2018
Q1
$61.3M Sell
478,256
-640
-0.1% -$86.5K 2.14% 6
2017
Q4
$66.9M Sell
478,896
-21,312
-4% -$2.97M 2.4% 5
2017
Q3
$65M Sell
500,208
-17,840
-3% -$2.36M 2.42% 4
2017
Q2
$68.5M Sell
518,048
-33,072
-6% -$4.22M 2.6% 4
2017
Q1
$68.6M Sell
551,120
-18,576
-3% -$2.22M 2.72% 5
2016
Q4
$65.6M Buy
+569,696
New +$65.8M 2.95% 5

Other funds holding JNJ

Neuburgh Advisers's JNJ Position: Q3 2019 in Review

Neuburgh Advisers increased its Johnson & Johnson (JNJ) stake by 9.1% in Q3 2019, buying an estimated $5.46M and bringing the position to 495,792 shares worth $64.1M. The position accounts for 1.99% of the portfolio, ranked #9.

Neuburgh Advisers first reported a position in JNJ in Q4 2016 and has held it in 12 quarters since. The position peaked at $68.6M in Q1 2017. 2,724 funds tracked by Wall St. Rank hold JNJ as of Q3 2019.

  • Neuburgh Advisers held 495,792 shares of Johnson & Johnson worth $64.1M as of Q3 2019.
  • Neuburgh Advisers bought 41,440 Johnson & Johnson shares in Q3 2019, an estimated $5.46M.
  • Johnson & Johnson made up 1.99% of Neuburgh Advisers's portfolio in Q3 2019, its #9 holding.
  • Neuburgh Advisers first reported a position in Johnson & Johnson in Q4 2016 and has held it in 12 quarters since.
  • Neuburgh Advisers's Johnson & Johnson position peaked at $68.6M in Q1 2017.
  • 2,724 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2019.

Based on Neuburgh Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.